A pharmacokinetic study of sublingual aerosolized morphine in healthy volunteers

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 12, 1996, Pages 1256-1259

  Watson, Neil W ^a   Taylor, Kevin M G ^b   Joel, Simon P ^c   Slevin, Maurice L ^c   Eden, Osborn B ^d  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; OPIATE;

ADULT; AEROSOL; ANALGESIA; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION;

EID: 0030458664     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb03932.x     Document Type: Article

References (13)

1. Al-Sayed-Omar, O., Johnston, A., Turner, P. (1987) Influence of pH on the buccal absorption of morphine sulphate and its major metabolite, morphine-3-glucuronide. J. Pharm. Pharmacol. 39: 934-935
2. British Pharmacopoeia, Vol. II (1993) HMSO, London, appendix XVIIC
3. Corish, J., Corrigan, O. I., Foley, D. (1990) The iontophoretic trans-dermal delivery of morphine hydrochloride and other salts across excized human stratum corneum. In: Scott, R. C., Guy, R. H., Hadgraft, J. (eds) Prediction of Percutaneous Penetration: Methods, Measurements, Modelling, IBC Technical Services, London, pp 302-307
4. Coyle, N. (1989) Continuity of care for the cancer patient with chronic pain. Cancer 63: 2289-2293
5. Hirsh, J. D. (1984) Sublingual morphine sulfate in chronic pain management. Clin. Pharm. 3: 585-586
6. Joel, S., Osborne, R. J., Slevin, M. (1988) An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites. J. Chromatogr. 430: 394-399
7. Johnston, A., Woolard, R. (1983) STRIPE: an interactive computer program for the analysis of drug pharmacokinetics. J. Pharmacol. Methods 9: 193-199
8. Osborne, R., Joel, S., Trew, D., Slevin, M. (1990) Morphine and metabolite behavior after different routes of morphine administration: determination of the importance of the active metabolite morphine-6-glucuronide. Clin. Pharmacol. Ther. 47: 12-19
9. Osborne, R., Thompson, P., Joel, S., Trew, D., Patel N., Slevin, M. (1992) The analgesic activity of morphine-6-glucuronide. Br. J. Clin. Pharmacol. 34: 130-138
10. Pannuti, F., Rossi, A. P., Iafelice, G., Marraro, D., Camera, P., Cricca, A., Strocchi, E., Burroni, P., Lapucci, L., Fruet, F. (1982) Control of chronic pain in very advanced cancer patients with morphine hydrochloride administered by oral, rectal, and sublingual route: clinical report and preliminary results on morphine pharmacokinetics. Pharmacol. Res. Commun. 4: 369-380
11. Smith, M. T., Watt, J. A., Cramond, T. (1990) Morphine-3-glucuronide: a potent antagonist of morphine analgesia. Life Sci. 47: 579-585
12. Svensson, J.-O., Rane, A., Säwe, J., Sjöqvist, F. (1982) Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. J. Chromatogr. 230: 427-432
13. Swerdlow, M., Stjernsward, J. (1982) Cancer pain relief: an urgent problem. World Health Forum 3: 325-330.